Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Vestn Khir Im I I Grek ; 154(3): 50-5, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-8743786

RESUMEN

Results of treatment of 24 patients with neglected colorectal tumors in the period from 1988 till 1994 are presented. Six patients had stage C and 18 patients had stage D after Dukes. Methods of combined action on the tumor including dissection of the tumor and its metastases, using immunoadoptive therapy as extracorporal connection with the donor porcine spleen, intravenous infusions of interleukin-2 and chemotherapy were employed. All the patients with stage C according to Dukes are alive: the average period of observations was 1143 +/- 206 days with intervals within the limits of 4,5-1,5 years. Seven patients of 18 with stage D after Dukes are alive with the average period of observations 1331 +/- 216 days and an interval of observations within the limits from 6 to 2 years. Dead patients with stage D after Dukes lived 525 +/-98 days on the average, i.e. about 1,4 year. The employed method of combined treatment of colorectal tumors improves survival, prolongs the lifetime of patients with neglected forms of the disease.


Asunto(s)
Neoplasias Colorrectales/terapia , Inmunoterapia Adoptiva , Adulto , Anciano , Neoplasias Colorrectales/mortalidad , Neoplasias Colorrectales/patología , Terapia Combinada , Femenino , Humanos , Inmunoterapia Adoptiva/métodos , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Estadificación de Neoplasias , Cuidados Posoperatorios , Factores de Tiempo
2.
Vestn Khir Im I I Grek ; 154(2): 57-60, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-8540190

RESUMEN

Clinical approbation of human recombinant yeast human interleukin-2 (rIL-2) was carried out in 10 patients with III-IV stages of tumor that have undergone 65 intravenous drop by drop infusions of the drug as a course of 5-11 injections in the dosage of 1-8 mln/un. The drug toxicity was shown in 4 mln and especially, in 8 mln/un dose administration. That's why the dose of 1-2 mln/un is recommended. This dose was not followed by any serious complications, and the number of slightly complicated cases was significantly decreased as compared to similar rIL-2 drug made by the "Cetus Corporation" firm. Immunostimulating effect of yeast rIL-2 was found which appeared to be able to reach it's maximum by 3-4 administrations, with it's following disappearance or inversion, which may cause immunosuppression.


Asunto(s)
Interleucina-2/administración & dosificación , Neoplasias/terapia , Adulto , Formación de Anticuerpos , Distribución de Chi-Cuadrado , Terapia Combinada , Femenino , Humanos , Inmunidad Celular , Infusiones Intravenosas , Interleucina-2/efectos adversos , Masculino , Persona de Mediana Edad , Neoplasias/sangre , Neoplasias/inmunología , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/efectos adversos , Vena Subclavia , Factores de Tiempo
3.
Anesteziol Reanimatol ; (6): 25-8, 1994.
Artículo en Ruso | MEDLINE | ID: mdl-7733474

RESUMEN

Clinical trials of Russian yeast recombinant human interleukin-2 (yrIL-2) were carried out in 17 patients with posttraumatic and postoperative sepsis to whom 33 intravenous drip infusions of the drug were administered as a single infusion or courses of 2 to 4 injections in a dose of 1,000,000 U per .1 m2 body surface. A positive clinical effect of yrIL-2 in this dose was observed on the next day after the first injection of the drug: the signs of intoxication were reliably reduced. The immunostimulating effect of yrIL-2 consisted in activation of pharmacytizing leukocytes of blood. Addition of yrIL-2 to therapeutic complex for patients with sepsis helped reliably reduce the mortality of such patients with sepsis helped reliably reduce the mortality of such patients to 29.4% vs. 63.3% in controls.


Asunto(s)
Interleucina-2/administración & dosificación , Complicaciones Posoperatorias/tratamiento farmacológico , Sepsis/tratamiento farmacológico , Adulto , Anciano , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/mortalidad , Sepsis/etiología , Sepsis/mortalidad , Factores de Tiempo
4.
Prehosp Disaster Med ; 7(1): 41-4, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-10149694

RESUMEN

INTRODUCTION: A principal cause of death following presumed recovery from an episode of shock is the development of shockogenic trauma [post-resuscitation syndrome]. The causes of this complication remain unclear and its various treatments continue to be controversial. HYPOTHESIS: The use of perfusion of the blood of patients suffering shockogenic trauma through a donor pig spleen will decrease the mortality from the complications of this process. METHODS: Freshly harvested pig spleens were adjoined to the venous circulation of patients suffering severe shockogenic trauma and the patient's blood perfused through them for periods of 30-60 minutes. The mortality rates of similar patients treated in this manner were compared with those not treated. Blood analyses included measures of the functions of the renal, immune, and coagulation systems. RESULTS: The experience with 212 Extracorporeal Joinings of Donor (pig) Spleens (EJDS) by means of a veno-venous shunt for the treatment of 86 patients with severe shock trauma and its complications is reported. The clinical effects consisted of decreasing signs of intoxication, namely reduction in fever and in the severity of associated encephalopathy. Extracorporeal joinings on donor (pig) spleens (EJDS) was followed by a decline in the concentration of "middle molecules," fibrinogen levels, leucocyte intoxication index, and the number of circulating immune complexes at different times following completion of the procedure. The number of blood cells remained constant. On the following day, there occurred an increase in the number of thrombocytes. In addition, there was a decline in the quantity of circulating particles in the plasma.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Circulación Extracorporea/mortalidad , Bazo/irrigación sanguínea , Animales , Humanos , Bazo/inmunología , Bazo/cirugía , Porcinos
5.
Vestn Khir Im I I Grek ; 143(9): 110-2, 1989 Sep.
Artículo en Ruso | MEDLINE | ID: mdl-2617763

RESUMEN

Twelve patients with traumatic shock caused by a mechanical trauma were treated with narcanti within 6 h after trauma with a single dose 0.4 mg, and then intravenously in drops (0.4 mg/100 ml of the sodium chloride solution) with the general dose 2.8 +/- 0.8 mg. It gave favourable hemodynamic and respiratory effects and contributed to stabilization of the indices of metabolism homeostasis.


Asunto(s)
Naloxona/administración & dosificación , Choque Traumático/tratamiento farmacológico , Heridas y Lesiones/complicaciones , Hemodinámica/efectos de los fármacos , Hemodinámica/fisiología , Homeostasis/efectos de los fármacos , Homeostasis/fisiología , Humanos , Infusiones Intravenosas , Inyecciones Intravenosas , Respiración/efectos de los fármacos , Respiración/fisiología , Choque Traumático/etiología , Choque Traumático/fisiopatología , Cloruro de Sodio/administración & dosificación , Soluciones
7.
Vestn Khir Im I I Grek ; 137(11): 81-6, 1986 Nov.
Artículo en Ruso | MEDLINE | ID: mdl-3824795

RESUMEN

The article presents results of using the extracorporal connection with the donor (porcine) spleen (ECCDS) for the treatment of 14 patients with critical mechanical traumas and their complications. An experience with 30 ECCDS-s has shown them to possess a pronounced detoxicating and immunomodulatory effect followed by a positive clinical result. In 6 cases of ECCDS a temporary chill was noted. There were no other complications.


Asunto(s)
Hemoperfusión/métodos , Choque Traumático/terapia , Bazo , Toxemia/prevención & control , Adolescente , Adulto , Animales , Cuidados Críticos , Femenino , Homeostasis , Humanos , Masculino , Persona de Mediana Edad , Choque Traumático/metabolismo , Porcinos
11.
Farmakol Toksikol ; 38(4): 458-63, 1975.
Artículo en Ruso | MEDLINE | ID: mdl-1213135

RESUMEN

The guthymine medication of a severe shock in rats started 10-20 minutes after injury is shown to eliminate energy metabolism disorders in the brain, liver and kidneys. In the brain of the guthamyine treated rats even a somewhat reduced adenosinetriphosphate content was demonstrable. Administration of guthymine together with polyglucin to cats in a torpid phase of the shock did not effect treir survival, but shortened the life-span of the test animals as compared to controls (receiving polyglucin alone). With guthymine addid to polyglucin the lactate and pyruvate concentration in the blood remained unchanged.


Asunto(s)
Amidinas/uso terapéutico , Choque Traumático/tratamiento farmacológico , Tiourea/análogos & derivados , Tiourea/uso terapéutico , Animales , Encéfalo/efectos de los fármacos , Gatos , Evaluación Preclínica de Medicamentos , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Masculino , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA